Article
Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society - 1 Jan 2000
Nakagawa Atsuko, Matsuoka Kentaro, Okita Hajime, Iwafuchi Hideto, Hori Hisanari, Kumagai Masaaki
Abstract excerpt
MYCN amplification prevents cellular differentiation and promotes mitotic and karyorrhectic activities in neuroblastomas. Hence, MYCN-amplified tumors typically show an appearance of neuroblastoma of either an undifferentiated or a poorly differentiated subtype with a high mitosis-karyorrhexis index. In addition, they are classified as part of the unfavorable histology group, according to the International...
Topics
- Adrenal Gland Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Combined Modality Therapy
- Female
- Gene Amplification
- Genotype
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Infant
- Male
